Healthcare
biospace.com
Isomorphic Labs Raises $2.1 Billion for AI Drug Discovery
Alphabet's DeepMind spinoff Isomorphic secured $2.1B Series B led by Thrive Capital to scale AlphaFold-based protein modeling and pharma partnerships in oncology/immunology.